Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, has received two suspension orders affecting store operations in Karnataka. The temporary closures, enforced by local drug control authorities, will impact store operations for two to three days. The company estimates a total potential revenue loss of Rs 2.52 lacs due to these short-term disruptions at the affected pharmacy locations.
Details of License Suspensions
On May 23, 2026, MedPlus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, received formal notices regarding the temporary suspension of drug licenses for two of its retail outlets in Karnataka. These orders were officially received on May 22, 2026, following alleged contraventions of established industry standards.
Impact on Retail Operations
The suspensions affect two specific pharmacy locations with varying durations and financial impacts:
- Kohinoor Road, Madikeri: The store license is suspended for two days, with a projected potential revenue loss of Rs 0.54 lacs.
- Nagarabhavi 2nd Stage, Bangalore: The store license is suspended for three days, resulting in a projected potential revenue loss of Rs 1.98 lacs.
Operational Outlook
The combined financial impact from these temporary store closures is estimated at Rs 2.52 lacs. MedPlus Health Services has confirmed the incident to the stock exchanges as part of its ongoing disclosure obligations to keep shareholders informed regarding operational developments.
Source: BSE
